CG
MDT icon

Corundum Group’s Medtronic MDT Stock Holding History

Corundum Group’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$894K Buy
10,313
+2,140
+26% +$205K 0.3% 64
2025
Q4 		$785K Sell
8,173
-254
-3% -$24.7K 0.26% 61
2025
Q3 		$803K Buy
8,427
+68
+0.8% +$6.25K 0.33% 60
2025
Q2 		$729K Buy
8,359
+328
+4% +$27.8K 0.32% 61
2025
Q1 		$722K Sell
8,031
-7,996
-50% -$716K 0.35% 62
2024
Q4 		$1.28M Buy
16,027
+8,237
+106% +$713K 0.48% 59
2024
Q3 		$701K Sell
7,790
-2,778
-26% -$234K 0.32% 63
2024
Q2 		$832K Buy
10,568
+4,931
+87% +$404K 0.33% 68
2024
Q1 		$491K Buy
+5,637
New +$481K 0.24% 70
2023
Q4 		– Sell
-9,452
Closed -$741K – 105
2023
Q3 		$741K Sell
9,452
-516
-5% -$43.2K 0.42% 54
2023
Q2 		$878K Sell
9,968
-5,022
-34% -$432K 0.44% 57
2023
Q1 		$1.21M Buy
14,990
+4,894
+48% +$399K 0.57% 52
2022
Q4 		$785K Buy
10,096
+1,004
+11% +$81.4K 0.44% 62
2022
Q3 		$734K Buy
9,092
+2,005
+28% +$180K 0.46% 54
2022
Q2 		$636K Buy
7,087
+681
+11% +$69K 0.43% 63
2022
Q1 		$711K Buy
6,406
+2,960
+86% +$313K 0.66% 59
2021
Q4 		$356K Buy
3,446
+1,161
+51% +$134K 0.23% 78
2021
Q3 		$286K Sell
2,285
-134
-6% -$17.3K 0.21% 80
2021
Q2 		$300K Buy
2,419
+108
+5% +$13.6K 0.2% 76
2021
Q1 		$273K Buy
2,311
+80
+4% +$9.38K 0.21% 73
2020
Q4 		$261K Buy
2,231
+64
+3% +$7.04K 0.22% 72
2020
Q3 		$225K Buy
+2,167
New +$218K 0.22% 73
2020
Q2 		– Sell
-2,262
Closed -$204K – 64
2020
Q1 		$204K Sell
2,262
-83
-4% -$8.83K 0.29% 53
2019
Q4 		$266K Buy
2,345
+73
+3% +$8.01K 0.28% 55
2019
Q3 		$247K Sell
2,272
-2
-0.1% -$209 0.29% 52
2019
Q2 		$221K Buy
2,274
+19
+0.8% +$1.74K 0.25% 58
2019
Q1 		$205K Sell
2,255
-4,363
-66% -$390K 0.23% 65
2018
Q4 		$602K Buy
+6,618
New +$618K 0.55% 39

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Corundum Group's MDT Position: Q1 2026 in Review

Corundum Group increased its Medtronic (MDT) stake by 26% in Q1 2026, buying an estimated $205K and bringing the position to 10,313 shares worth $894K. The position accounts for 0.3% of the portfolio, ranked #64.

Corundum Group first reported a position in MDT in Q4 2018 and has held it in 28 quarters since. The position peaked at $1.28M in Q4 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Corundum Group held 10,313 shares of Medtronic worth $894K as of Q1 2026.
  • Corundum Group bought 2,140 Medtronic shares in Q1 2026, an estimated $205K.
  • Medtronic made up 0.3% of Corundum Group's portfolio in Q1 2026, its #64 holding.
  • Corundum Group first reported a position in Medtronic in Q4 2018 and has held it in 28 quarters since.
  • Corundum Group's Medtronic position peaked at $1.28M in Q4 2024.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Corundum Group's 13F filing for Q1 2026, filed 20 Apr 2026.